Thermo Fisher Scientific Inc. Peer Comparison
| Metric | Value | Ranking | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $214.1 Billion | 1/10 | TMO $214.1B |
DHR $172.2B |
A $42.1B |
IDXX $34.3B |
MTD $27.3B |
WAT $24.0B |
ILMN $21.7B |
CRL $8.4B |
GH $4.5B |
NVTA $5.7M |
| Gross Margin | 42% | 7/10 | A 100% |
GH 100% |
ILMN 69% |
MTD 64% |
WAT 63% |
IDXX 61% |
TMO 42% |
CRL 35% |
NVTA 32% |
DHR 30% |
| Profit Margin | 15% | 7/10 | ILMN 65% |
DHR 24% |
IDXX 24% |
WAT 22% |
MTD 22% |
A 21% |
TMO 15% |
CRL 7% |
GH -56% |
NVTA -100% |
| EBITDA margin | 17% | 6/10 | ILMN 76% |
DHR 28% |
A 24% |
MTD 23% |
IDXX 21% |
TMO 17% |
CRL 12% |
WAT 6% |
GH -61% |
NVTA -808% |
| Quarterly Revenue | $10.6 Billion | 1/10 | TMO $10.6B |
DHR $3.4B |
A $1.7B |
ILMN $1.1B |
CRL $1.0B |
IDXX $975.5M |
MTD $954.5M |
WAT $740.3M |
GH $191.5M |
NVTA $121.2M |
| Quarterly Earnings | $1.6 Billion | 1/10 | TMO $1.6B |
DHR $818.0M |
ILMN $705.0M |
A $351.0M |
IDXX $232.8M |
MTD $211.5M |
WAT $161.5M |
CRL $69.7M |
GH -$107.8M |
NVTA -$942.1M |
| Quarterly Free Cash Flow | $2.8 Billion | 1/10 | TMO $2.8B |
DHR $1.2B |
ILMN $284.0M |
MTD $233.2M |
CRL $213.1M |
IDXX $192.0M |
WAT $179.0M |
GH -$55.3M |
NVTA -$66.9M |
A -$0 |
| Trailing 4 Quarters Revenue | $42.4 Billion | 1/10 | TMO $42.4B |
DHR $18.7B |
A $6.5B |
ILMN $4.4B |
CRL $4.1B |
IDXX $3.8B |
MTD $3.8B |
WAT $2.9B |
GH $692.3M |
NVTA $481.6M |
| Trailing 4 Quarters Earnings | $6.1 Billion | 1/10 | TMO $10.6B |
DHR $3.4B |
A $1.7B |
ILMN $1.1B |
CRL $1.0B |
IDXX $975.5M |
MTD $954.5M |
WAT $740.3M |
GH $191.5M |
NVTA $121.2M |
| Quarterly Earnings Growth | -5% | 5/10 | ILMN 194% |
WAT 20% |
IDXX 10% |
MTD 5% |
TMO -5% |
CRL -20% |
GH -25% |
A -26% |
DHR -28% |
NVTA -213% |
| Annual Earnings Growth | 6% | 4/10 | NVTA 82% |
A 60% |
CRL 9% |
TMO 6% |
WAT 6% |
IDXX -2% |
MTD -6% |
ILMN -9% |
DHR -12% |
GH -68% |
| Quarterly Revenue Growth | 0% | 6/10 | GH 34% |
IDXX 7% |
WAT 4% |
A 1% |
MTD 1% |
TMO 0% |
CRL -2% |
ILMN -3% |
NVTA -9% |
DHR -51% |
| Annual Revenue Growth | -1% | 3/10 | GH 25% |
IDXX 3% |
TMO -1% |
DHR -1% |
WAT -1% |
A -3% |
CRL -3% |
MTD -3% |
ILMN -6% |
NVTA -11% |
| Cash On Hand | $4.6 Billion | 1/10 | TMO $4.6B |
DHR $2.6B |
A $1.3B |
ILMN $869.0M |
GH $688.4M |
WAT $331.5M |
IDXX $308.6M |
CRL $210.2M |
NVTA $158.0M |
MTD $71.6M |
| Short Term Debt | $4.1 Billion | 1/10 | TMO $4.1B |
DHR $1.2B |
IDXX $349.1M |
MTD $185.8M |
ILMN $73.0M |
A $45.0M |
WAT $25.3M |
NVTA $21.6M |
CRL $3.2M |
GH -$0 |
| Long Term Debt | $31.2 Billion | 1/10 | TMO $31.2B |
DHR $16.3B |
A $3.3B |
CRL $2.8B |
ILMN $2.6B |
MTD $1.9B |
NVTA $1.5B |
GH $1.3B |
IDXX $524.8M |
WAT $0 |
| PE | 34.89 | 4/10 | DHR 44.23 |
IDXX 39.63 |
WAT 38.53 |
TMO 34.89 |
MTD 34.36 |
A 32.65 |
CRL 20.19 |
ILMN -1.00 |
NVTA -1.00 |
GH -1.00 |
| PS | 5.05 | 7/10 | DHR 9.20 |
IDXX 8.93 |
WAT 8.26 |
MTD 7.27 |
GH 6.54 |
A 6.46 |
TMO 5.05 |
ILMN 4.94 |
CRL 2.06 |
NVTA 0.01 |
| PB | 4.37 | 5/10 | IDXX 21.22 |
WAT 14.96 |
ILMN 8.89 |
A 7.14 |
TMO 4.37 |
DHR 3.36 |
CRL 2.18 |
MTD 0.00 |
NVTA 0.00 |
GH 0.00 |
| PC | 46.09 | 5/10 | MTD 381.94 |
IDXX 111.23 |
WAT 72.37 |
DHR 65.54 |
TMO 46.09 |
CRL 39.78 |
A 31.67 |
ILMN 24.94 |
GH 6.58 |
NVTA 0.04 |
| Liabilities to Equity | 1.05 | 5/10 | WAT 1.81 |
ILMN 1.47 |
CRL 1.10 |
IDXX 1.07 |
TMO 1.05 |
MTD 1.05 |
A 1.01 |
DHR 0.57 |
NVTA 0.00 |
GH 0.00 |
| ROA | 0.06 | 5/10 | IDXX 26% | MTD 24% | WAT 14% | A 11% | TMO 6% | DHR 5% | CRL 5% | ILMN -26% | GH -33% | NVTA -269% |
| ROE | 0.13 | 7/10 | GH 853% |
NVTA 133% |
IDXX 54% |
WAT 39% |
MTD 24% |
A 22% |
TMO 13% |
CRL 11% |
DHR 8% |
ILMN -65% |
| Current Ratio | 1.95 | 3/10 | DHR 2.75 |
A 1.99 |
TMO 1.95 |
IDXX 1.93 |
CRL 1.92 |
ILMN 1.68 |
WAT 1.55 |
MTD 0.96 |
GH 0.96 |
NVTA 0.33 |
| Quick Ratio | 0.13 | 6/10 | DHR 44.23 |
IDXX 39.63 |
WAT 38.53 |
TMO 34.89 |
MTD 34.36 |
A 32.65 |
CRL 20.19 |
ILMN -1.00 |
NVTA -1.00 |
GH -1.00 |
| Long Term Debt to Equity | 0.64 | 3/10 | ILMN} 1.07 |
CRL} 0.73 |
TMO} 0.64 |
A} 0.57 |
MTD} 0.57 |
DHR} 0.32 |
IDXX} 0.32 |
WAT} 0.00 |
NVTA} -1.37 |
GH} -21.83 |
| Debt to Equity | 0.72 | 3/10 | ILMN 1.07 |
CRL 0.73 |
TMO 0.72 |
MTD 0.63 |
A 0.57 |
IDXX 0.54 |
DHR 0.34 |
WAT 0.02 |
NVTA -1.39 |
GH -21.83 |
| Burn Rate | 7.18 | 2/10 | DHR 19.47 |
TMO 7.18 |
CRL 5.06 |
GH 4.30 |
NVTA 0.16 |
MTD -0.80 |
ILMN -1.49 |
WAT -2.14 |
IDXX -2.48 |
A -6.45 |
| Cash to Cap | 0.02 | 6/10 | NVTA 27.58 |
GH 0.15 |
ILMN 0.04 |
A 0.03 |
CRL 0.03 |
TMO 0.02 |
DHR 0.02 |
IDXX 0.01 |
WAT 0.01 |
MTD 0.00 |
| CCR | 1.73 | 2/10 | CRL 3.06 |
TMO 1.73 |
DHR 1.49 |
WAT 1.11 |
MTD 1.10 |
IDXX 0.82 |
GH 0.51 |
ILMN 0.40 |
NVTA 0.07 |
A |
| EV to EBITDA | 133.15 | 5/10 | WAT} 565.96 |
DHR} 195.26 |
IDXX} 168.10 |
MTD} 135.68 |
TMO} 133.15 |
A} 108.20 |
CRL} 92.93 |
ILMN} 28.34 |
NVTA} -1.38 |
GH} -43.92 |
| EV to Revenue | 5.78 | 7/10 | DHR 9.99 |
IDXX 9.08 |
WAT 8.15 |
MTD 7.80 |
GH 7.44 |
A 6.78 |
TMO 5.78 |
ILMN 5.33 |
NVTA 2.82 |
CRL 2.69 |